Two Boats, a Helicopter & Stem Cells

Saltzman, Russell E.
October 1999
First Things: A Monthly Journal of Religion & Public Life;Oct1999, Issue 96, p13
Opinion. Offers observations on the therapeutic use of stem cell in the treatment of diabetes in the United States. Experiences of the author as a diabetic; Accounts of other diabetics; Federal law regulation on stem cells researches; Moral arguments on stem cell therapy.


Related Articles

  • Scientists say placenta may ease stern-cell debate. MacPherson, Kitta // National Catholic Reporter;1/26/2007, Vol. 43 Issue 13, p5 

    The article reports that first-time parents Greg and Didi Bogert from New Jersey will become pioneers in the science of stem-cell technology. The couple are part of a small group choosing to store stem cells extracted from the placenta. The stem cells will be stored at the biotechnology firm...

  • FROM THE EDITORS. Rhodes, Rosamond; Sheldon, Mark // APA Newsletters;Spring2007, Vol. 6 Issue 2, p1 

    The article discusses various reports published within the issue, including a reprint of the article "Ethical Issues in Using and Not Using Embryonic Stem Cells," by Frances M. Kamm and a review of Tony Hope's book "Medical Ethics: A Very Short Introduction."

  • Pro-life and anti-ethics. Grayling, A. C. // New Scientist;12/22/2007, Vol. 196 Issue 2635/2636, p76 

    The author asserts that the use of embryonic stem cells in medical research is pro-life, in that the use of potential life is used to further the cures of people already alive. A discussion of the the use of the 30 cells in a blastocyst, which are surplus after in-vitro fertilization processes,...

  • Stress can make stem cells. Investor's Business Daily // Investors Business Daily;2/ 4/2014, pA02 

    Embryonic stem cells can be turned into any type of cell, but harvesting the cells requires destroying an embryo, which raises ethical concerns. But scientists in Japan and Harvard have found that putting mature mice cells in an stressful environment that included trauma, low oxygen levels and...

  • Stem Cell Therapy for Diabetes: Are We Close Enough? Kadam, Sachin S. // Journal of Krishna Institute of Medical Sciences (JKIMSU);Jan-Jun2014, Vol. 3 Issue 1, p6 

    Over the last few decades, understanding of the mechanism of cellular development has increased tremendously. The knowledge of the potential of stem/precursor cells in tissue engineering and cell therapy has gained the popularity. In case of diabetes, the availability of the source of stem cells...

  • Rapid Publication: Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Soria, Bernat; Roche, Enrique; Berna, Genoveva; Leon-Quinto, Trinidad; Reig, Juan A.; Martin, Franz // Diabetes;Feb2000, Vol. 49 Issue 2, p157 

    Focuses on an insulin-secreting cell clone derived from undifferentiated embryonic stem (ES) cells. Expression of a neomycin selection system; Hygromycin resistance gene; Regulated hormone secretion in vitro in the presence of various secretagogues; Possibilities for tissue transplantation in...

  • Promises, Promises. Callahan, Daniel // Commonweal;1/14/2005, Vol. 132 Issue 1, p12 

    Addresses the campaign for embryonic stem-cell research in the U.S. organized by Robert Klein II. Definition of embryonic stem-cell research; Benefits of stem-cell research in the cure of deadly diseases; Information on the ethical and moral issues surrounding the campaign.

  • Regulating stem cell research in Europe by the back door. Holm, S. // Journal of Medical Ethics;Aug2003, Vol. 29 Issue 4, p203 

    Comments on the issue on regulating stem cell research in Europe. Draft directive on setting standards of quality and safety of the research prepared by the European Commission; Ethical status of human embryonic stem cells; Comparison of the European Commission and European Parliament texts. ...

  • Consent to the use of aborted fetuses in stem cell research and therapies. Pfeffer, N.; Kent, J. // Clinical Ethics;2006, Vol. 1 Issue 4, p216 

    This paper identifies the legal and policy framework relating to the use of aborted fetuses in stem cell research and therapies and contrasts this with the collection of embryos for research. It suggests that more attention should be given to questions about the kind of consent sought by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics